FDA is initiating a pilot program that would allow quarterly reporting of MDRs for certain Class I and Class II devices in situation that do not reult in death or serious injury or a correction is not needed to prevent this. Companies can apply to participate in this pilot as indicated in the FDA announcement at the link provided.